Euroasian Journal of Hepato-Gastroenterology

Register      Login

VOLUME 7 , ISSUE 2 ( July-December, 2017 ) > List of Articles

RESEARCH ARTICLE

Adrenal Insufficiency in Cirrhosis Patients: Evaluation of 108 Case Series

Hali Rakici

Citation Information : Rakici H. Adrenal Insufficiency in Cirrhosis Patients: Evaluation of 108 Case Series. Euroasian J Hepatogastroenterol 2017; 7 (2):150-153.

DOI: 10.5005/jp-journals-10018-1237

License: CC BY 3.0

Published Online: 01-12-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim

Adrenal insufficiency (AI) in cirrhosis is an issue that has recently gained momentum. It can be seen in both stable and critically ill (sepsis, septic shock, and gastrointestinal system bleeding) cirrhotic patients. Its prevalence exists in a wide range since standardization of diagnostic methods is lacking. We aimed to scrutinize this issue in a 108 case series.

Materials and methods

We studied the presence of AI and its stage in patients with cirrhosis and its complications by using cross-sectional study. Standard-dose short synacthen test (SD-SST) was performed in 108 patients that had Child C decompensated cirrhosis without critical illness and it was aimed to determine the prevalence of AI based on basal cortisol, peak cortisol, and delta cortisol (basal total cortisol minus peak cortisol after stimulation) levels.

Results

The prevalence of AI in cirrhosis was found to be 25% based on basal cortisol level of <140 nmol/L, 22.2% based on delta cortisol level of <250 nmol/L, and 29.6% based on peak cortisol level of <500 nmol/L.

Conclusion

Prevalence of AI shows variation in decompensated cirrhosis without critical illness depending on different measures used. More definite results can be obtained when more standardized criteria are widely put into use.

How to cite this article

Rakici H. Adrenal Insufficiency in Cirrhosis Patients: Evaluation of 108 Case Series. Euroasian J Hepato-Gastroenterol 2017;7(2):150-153.


  1. Update on adrenal insufficiency in patients with liver cirrhosis. World J Gastroenterol 2013 Jan;19(4):445-456.
  2. Adrenocortical dysfunction in liver disease: a systematic review. Hepatology 2012 Apr;55(4):1282-1291.
  3. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 2005 Jun;33(6):1254-1259.
  4. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 2006 Apr;43(4):673-681.
  5. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016 Feb;101(2):364-389.
  6. Characterising adrenal function using directly measured plasma free cortisol in stable severe liver disease. J Hepatol 2010 Nov;53(5):841-848.
  7. Critical illness-related corticosteroid insufficiency in patients with cirrhosis and variceal bleeding. Clin Gastroenterol Hepatol 2011 Jul;9(7):595-601.
  8. Adrenal insufficiency in liver disease — what is the evidence? J Hepatol 2007 Sep;47(3):418-423.
  9. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002 Nov;122(5):1784-1796.
  10. Hepatoadrenal syndrome: prevalence and factors predicting adrenalin sufficiency in critically ill patients with liver disease. Am J Respir Crit Care Med 2009;179:A1588.
  11. Assessment of adrenocortical reserve in stable patients with cirrhosis. J Hepatol 2011 Feb;54(2):243-250.
  12. Adrenal dysfunction in nonseptic cirrhotic patients with ascites: impact on survival. Dig Liv Dis 2011;43(Suppl 2):S74-S75.
  13. Prognostic value of relative adrenal insufficiency in decompensated cirrhosis. J Hepatol 2010 Apr;52(Suppl 1):S65.
  14. Incidence and prognostic significance of relative adrenal insufficiency in cirrhotic patients with severe variceal bleeding (abstract). The Liver Meeting® 2010 (AASLD). Hepatology 2010;52(Suppl 1):267A.
  15. Prevalence of adrenocortical insufficiency in patients with liver cirrhosis, liver cirrhosis with septic shock and in patients with hepatorenal syndrome. J Am Sci 2011;7(6):391-400.
  16. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001 Jan;34(1):32-37.
  17. Adrenal-exhaustion syndrome in patients with liver disease. Intensive Care Med 2006 Feb;32(2):275-280.
  18. Assessing adrenal function in cirrhotic patients: is there a reliable test? Gastroenterol Clin Biol 2009 Jun-Jul;33(6-7):584-588.
  19. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 1997 Apr;157(7):792-796.
  20. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005 Aug;33(8):1688-1693.
  21. Assessment of adrenal function in cirrhotic patients using concentration of serum-free and salivary cortisol. Liver Int 2011 Mar;31(3):425-433.
  22. ; Acevedo, J. Adrenal function in chronic liver failure. In: Ginès P, Kamath PS, Arroyo V, editors. Chronic liver failure: mechanisms and management. New York: Humana Press Inc; 2011. p. 377-391.
  23. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J Hepatol 2010 Jun;52(6):839-845.
  24. High serum levels of free cortisol indicate severity of cirrhosis in hemodynamically stable patients. J Gastroenterol Hepatol 2012 Oct;27(10):1596-1601.
  25. Predisposing factors for adrenal insufficiency. N Engl J Med 2009 May;360(22):2328-2339.
  26. Adrenal impairment is frequent finding in stable cirrhosis and is related to disease severity. Hepatology 2007;46(Suppl 1):573A-573A.
  27. Relative adrenal insufficiency in cirrhosis: relevance in patients with ascites and treatment with hydrocortisone in refractory ascites. Digest Liver Dis 2009 Mar;41(3):A13.
  28. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology 2006 Nov;44(5):1288-1295.
  29. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ 2010 Dec;182(18):1971-1977.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.